Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breast Cancer

Clinical trial NCT07531693 · RECRUITING

Trial details

NCT number: NCT07531693
Sponsor: Institut fuer Frauengesundheit
Status: RECRUITING
Study type: OBSERVATIONAL

HR+/HER2- Early Breast Cancer

Start date: 2026-02-19
Primary completion: 2026-09-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.